Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
What medications are you on
It is the first cell protection molecule and the main neutraliser of toxic and polluting agents
In 2010, 0.1% of T1D patients were treated with SGLT2 inhibitors, rising significantly to 2.4% in 2023
Short-term (weeks to months), the refrigerator is fine
Consumer demand is accelerating, oral formulations are nearing the market, Medicare negotiations are set to reshape pricing, pivotal trial readouts in Alzheimers and chronic kidney disease could unlock entirely new indications, and the market is forecast to top $100 billion by 2030
J Neuroci Res
US$ 21.32
US$ 20.82
US$ 24.55
